Viewing Study NCT04182568


Ignite Creation Date: 2025-12-24 @ 5:43 PM
Ignite Modification Date: 2026-02-11 @ 9:42 AM
Study NCT ID: NCT04182568
Status: UNKNOWN
Last Update Posted: 2019-12-02
First Post: 2019-11-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Nab-paclitaxel Compared With Docetaxel Followed by Anthracyclines and Cyclophosphamide in the Neoadjuvant Breast Cancer
Sponsor: Xijing Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords: